AdvaMed has announced the appointment of Melissa Torres as the new Executive Vice President of Technology and Regulatory Affairs. This strategic move comes as Janet Trunzo retires after three decades of dedicated service to the medical device industry association.
Importance of the Role
Scott Whitaker, President and CEO of AdvaMed, emphasized the significance of the technology and regulatory affairs department in facilitating patient access to safe and effective medical technologies. He stated that the department plays a pivotal role in advocating for transparent and efficient processes, enabling innovators to successfully navigate complex regulatory landscapes. Whitaker expressed confidence in Torres’ extensive experience with the FDA, positioning her well to lead this critical area.
Seamless Transition
Whitaker highlighted the seamless transition from Trunzo to Torres, noting the legacy and high standards Trunzo leaves behind. This continuity is crucial for maintaining the value that AdvaMed provides to its member companies and the patients they serve.
Torres’ Extensive Experience
With over 20 years of leadership experience at the FDA and in international regulatory policy, Torres brings a wealth of knowledge to her new role. Prior to joining AdvaMed, she served as the associate director for international affairs at the FDA’s Center for Devices and Radiological Health (CDRH). Her extensive background includes shaping regulatory frameworks for medical devices and managing high-impact teams throughout premarket and post-market activities.
Proven Track Record
Torres has demonstrated her capabilities in regulatory policy development and global strategy. Her experience encompasses stakeholder engagement and cross-functional leadership, making her a well-rounded candidate for this position. Her previous responsibilities included overseeing FDA participation in significant international initiatives such as the International Medical Device Regulators Forum (IMDRF) and the Medical Device Single Audit Program (MDSAP).
Contributions to Regulatory Developments
In her previous roles, Torres played a vital part in developing the Quality Management System Regulation (QMSR) and was actively involved in prior negotiations related to the Medical Device User Fee Amendments (MDUFA). Her contributions have been instrumental in advancing regulatory processes within the medical device sector, reflecting her commitment to enhancing industry standards.
The Future of AdvaMed
As Torres steps into her new position, the industry watches closely to see how her leadership will shape the future of AdvaMed’s regulatory affairs. Her extensive background and proven track record suggest a promising direction for both the organization and its stakeholders.
Key Takeaways
- Melissa Torres appointed as Executive Vice President of Technology and Regulatory Affairs at AdvaMed.
-
Scott Whitaker praises the importance of the department in ensuring patient access to safe medical technologies.
-
Torres brings over 20 years of regulatory experience, primarily from her tenure at the FDA.
-
She has previously led key international initiatives and contributed to significant regulatory developments.
-
The transition from Janet Trunzo to Torres is designed to maintain continuity and uphold high standards.
In conclusion, Melissa Torres’ appointment as EVP of Technology and Regulatory Affairs marks a significant milestone for AdvaMed. Her extensive experience and leadership capabilities will undoubtedly contribute to advancing the medical device industry’s regulatory framework, benefiting both innovators and patients alike. The future looks bright under her guidance.
Read more → www.medicaldesignandoutsourcing.com